The coronavirus pandemic hammering the global economy is taking a hefty toll on people of color in the United States, and top officials are taking notice. …read more […]
The markets rallied this week, despite over 16 Million losing their jobs during the COVID-19 pandemic. Specifically the S&P, which rose 12.1%…it’s best week since 1974. The Nasdaq went up 10.6% and the Dow an astounding 12%. There are many individual stocks that went up this week. Let’s take a look at 5 with large % gains over the past 5 days.
Since the market started declining, we’ve continued to deliver the latest and greatest investment opportunities right to your inbox. This list is no exception. Sign-Up for our FREE InvesmentU E-letter below.
The markets were closed for Good Friday, but that …read more […]
What are billionaires doing and how much money are they giving to fight COVID-19? …read more […]
Regular readers will know that we love our dividends at Simply Wall St, which is why it’s exciting to see Abbott… …read more […]
Hackers have accessed the mailboxes of some employees at Italian state-owned bank Monte dei Paschi ‹BMPS.MI› and sent emails to clients, according to a notice to customers seen by Reuters.
The European Commission has imposed provisional anti-dumping duties on some stainless steel products from China, Indonesia and Taiwan, according to the official EU journal, nearly eight months after launching a probe into low-price imports.
Anthony Scaramucci predicts Doald Trump will ultimately be stymied by the recession and lose in November. …read more […]
Yahoo Finance’s editor-in-chief Andy Serwer talks with John Paul Dejoria the co-founder of the Paul Mitchell line of hair products and The Patrón Spirits Company. Dejoria discusses the work he has done to aid his home state of Texas as well as how Paul Mitchell is supporting those in need along with their employees and salons during the coronavirus crisis. …read more […]
Siemens will not cut its workforce because of the economic downturn triggered by the new coronavirus, Chief Executive Joe Kaeser said, although short-time working measures could be extended in Germany.
The company said it had entered into an agreement with the National Institute of Allergy and Infectious Diseases to study the baricitinib drug to examine its efficacy and safety as a potential treatment for hospitalized patients diagnosed with COVID-19. Lilly had previously been testing the Olumiant or baricitinib drug as a treatment for atopic dermatitis. Lilly said it currently does not anticipate shortages for any of its medicines, including baricitinib. …read more […]
The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included — in one case because of a dosing error. The paper’s author called the findings “hopeful,” but cautioned that it is difficult to interpret the results since they do not include comparison to a control group, as would be the case in a randomized clinical trial. Gilead last month sharply limited its compassionate use program for remdesivir and is conducting its own clinical trials of …read more […]
Apple Inc and Alphabet Inc’s Google said on Friday that they will work together to create contact tracing technology that aims to slow the spread of the coronavirus by allowing users to opt into logging other phones they have been near.
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
